Philips NV

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Real-time Euronext Amsterdam Other stock markets 10:30:45 2024-04-23 am EDT			5-day change	1st Jan Change
19.56 ^EUR	+2.41%		+2.09%	-7.23%

Apr. 18	PHILIPS NV : Receives a Sell rating from Jefferies	ZD
Apr. 15	European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	MT

PHILIPS NV : Credit Suisse reaffirms its Neutral rating

October 25, 2021 at 06:01 am EDT

In a research note, Credit Suisse analyst Max Yates has maintained his recommendation on the stock with a Neutral rating. The target price is decreased from EUR 49 to EUR 42.

Latest news about Philips NV

PHILIPS NV : Receives a Sell rating from Jefferies	Apr. 18	ZD
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
HSBC Upgrades Koninklijke Philips to Hold From Reduce	Apr. 12	MT
Agnellis' Exor targets growth in healthcare sector	Apr. 11	RE
Trending : Philips in Final Agreement With DOJ, FDA on Ventilators	Apr. 10	DJ
Sector Update: Health Care Stocks Decline Premarket Wednesday	Apr. 10	MT
Sector Update: Health Care	Apr. 10	MT
Philips shares rise on final US deal on sleep apnea machines	Apr. 10	RE
Tech stocks power STOXX 600 higher; Barry Callebaut jumps	Apr. 10	RE
Philips: final approval for U.S. settlement	Apr. 10	CF
Royal Philips' Subsidiaries Plan to Complete Remediation of Sleep, Respiratory Devices Following Deal With FDA	Apr. 10	MT
Philips announces terms of US government deal on sleep apnea machines	Apr. 10	RE
Philips Reaches Final Pact With DoJ, FDA on Ventilator Recall -- Update	Apr. 10	DJ
Tech stocks lead STOXX 600 higher; Barry Callebaut shimmers	Apr. 10	RE
Royal Philips Finalizes Consent Decree Agreement for US Respironics Business	Apr. 10	MT
Philips to Remain Restricted from Selling New Respiratory Devices in US Under Final Consent Decree	Apr. 10	MT
US federal court orders to restrict production of Philips' sleep apnea devices	Apr. 09	RE
Federal court enters agreement to restrict production of new Philips' sleep apnea devices	Apr. 09	RE
Philips: strategic partnership with smartQare	Apr. 04	CF
ROYAL PHILIPS : Philips’ recovery story remains intact	Apr. 04
Royal Philips Partners With March of Dimes for Prenatal Technology Services	Apr. 04	MT
PHILIPS NV : Barclays keeps its Buy rating	Apr. 03	ZD
Target shopper data, streaming TV ads are key to its sales	Apr. 02	RE
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	Mar. 28	MT
PHILIPS NV : Sell rating from Deutsche Bank	Mar. 28	ZD

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-29 - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ROYAL PHILIPS : Philips’ recovery story remains intact

April 04, 2024 at 11:08 am EDT

Philips NV : The sleep apnea case makes a brutal comeback

October 06, 2023 at 05:20 am EDT

Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO

September 29, 2023 at 10:33 am EDT

More Strategies

Ratings for Philips NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

19.1 EUR

Average target price

20.36 EUR

Spread / Average Target

+6.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PHILIPS NV	-7.23%	18.43B
THERMO FISHER SCIENTIFIC	+7.03%	209B
DANAHER CORPORATION	+8.51%	175B
INTUITIVE SURGICAL, INC.	+10.56%	131B
BOSTON SCIENTIFIC CORPORATION	+18.16%	99.98B
SIEMENS HEALTHINEERS AG	-0.87%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+14.57%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.15%	46.5B
AGILENT TECHNOLOGIES, INC.	-1.04%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+10.41%	38.47B

Other Advanced Medical Equipment & Technology

Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

PHILIPS NV : Credit Suisse reaffirms its Neutral rating

Latest news about Philips NV

Chart Philips NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Philips NV

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology